购物车
- 全部删除
- 您的购物车当前为空
MK-912 is a potent novel selective alpha2-adrenergic receptor antagonist with oral activity to study the effect of short-term selective alpha2-blockers on fasting glucose (FPG) and islet function in non-insulin-dependent patients with diabetes mellitus (NIDDM).
MK-912 is a potent novel selective alpha2-adrenergic receptor antagonist with oral activity to study the effect of short-term selective alpha2-blockers on fasting glucose (FPG) and islet function in non-insulin-dependent patients with diabetes mellitus (NIDDM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 41,500 | 6-8周 |
产品描述 | MK-912 is a potent novel selective alpha2-adrenergic receptor antagonist with oral activity to study the effect of short-term selective alpha2-blockers on fasting glucose (FPG) and islet function in non-insulin-dependent patients with diabetes mellitus (NIDDM). |
别名 | MK912, MK 912 |
分子量 | 375.89 |
分子式 | C20H26ClN3O2 |
CAS No. | 119942-70-0 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容